about
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin TreatmentNew prospects in the diagnosis and treatment of immune-mediated inner ear diseaseExtended high-frequency (9-20 kHz) audiometry reference thresholds in 645 healthy subjects.Effect of intratympanic dimethyl sulphoxide (DMSO) in an in vivo model of cisplatin-related ototoxicity.In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.Enlarged vestibular aqueduct: Looking for genotypic-phenotypic correlations.Examination of Hearing in a Rheumatoid Arthritis Population: Role of Extended-High-Frequency Audiometry in the Diagnosis of Subclinical Involvement.Diagnostic tests for immunomediated hearing loss: a systematic review.Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models.Review of the biologic agents used for immune-mediated inner ear disease.Eosinophilic esophagitis: A relevant entity for the otolaryngologist.Earphones in extended high-frequency audiometry and ISO 389-5.Biofilm colonisation in nasolacrimal stents.Central role of supporting cells in cochlear homeostasis and pathology.Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.Hearing threshold levels for an otologically screened population in Spain.Promising Technique for Facial Nerve Reconstruction in Extended Parotidectomy.Cogan's syndrome: an oculo-audiovestibular disease.Spontaneous otitis media in Wistar rats: an overlooked pathology in otological research.Clinical-scintigraphy discordance in a case of malignant external otitis.Pseudomonas aeruginosa infection in the hypoventilated middle ear: an experimental model.[Consensus on diagnosis and treatment of sudden hearing loss. Asociación Madrileña de ORL].Blood loss in endoscopic sinus surgery: assessment of variables.[Early cellular immune response in experimental labyrinthitis: immunohistochemical study]Adverse effects of glucocorticoid therapy for inner ear disorders.[Removal and processing inner ear specimens for morphological research on guinea pig ear]Analysis of audiometric relapse-free survival in patients with immune-mediated hearing loss exclusively treated with corticosteroids.Patient-derived olfactory mucosa cells but not lung or skin fibroblasts mediate axonal regeneration of retinal ganglion neurons.Sudden hearing loss: National survey in Spain.Extended high-frequency audiometry (9,000-20,000 Hz). Usefulness in audiological diagnosis.Extended high frequency audiometry can diagnose sub-clinic involvement in a seemingly normal hearing systemic lupus erythematosus population.Radiology quiz case 2. Posterior semicircular canal dehiscence.Endogenous protection against oxidative stress caused by cisplatin: role of superoxide dismutase.[Intervention of spiral ligament fibrocytes in the metabolic regulation of the inner ear].Blebs in inner and outer hair cells: a pathophysiological hypothesis.[Autoimmune hearing loss: improving diagnostic performance].Otosyphilis mimics immune disorders of the inner ear.Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis.Immunologic work-up study for inner ear disorders: looking for a rational strategy.
P50
Q27324350-B047295F-9CF1-4CC6-95A9-25AFD6D56109Q34367600-E5242D2A-2488-4E94-99EB-42FB3B384D7FQ34416173-63118CA6-6168-4752-8D88-57A7FD334297Q35115020-A8A9B53F-3A95-4C9A-A0CA-3DFB6171FBF3Q35916310-D34DE548-87A2-48D1-AE13-9B4796ADCD01Q36531680-2BB7141D-C12C-4409-B0A9-53EEBA1CE7ACQ36889852-1CBE4433-1616-4518-A18D-FAA1A9A04E38Q36956929-9C6100D6-C0D1-4799-9408-7ACBB947D18CQ38010040-4637A01E-FF6D-4D63-8A03-8ED33DB0F8F9Q38024421-973623EF-151C-4753-8CF2-55932F6C2758Q38603256-B226AFEF-AD1B-4BB7-9FC5-5053E6AB377AQ39199062-FA513098-041D-4B5F-87BF-6AB252222E97Q39751249-BC0C9377-6CBF-4E90-98C4-7667498C4AB3Q40331943-93239790-9AF6-4E34-B8F9-00F8808FF3B0Q40745229-46C5AD8D-7655-40AE-8CB6-8B4AFF259D2FQ41127701-C7EB70C9-FFCF-48E2-8267-90111121A39CQ41815535-27C685BA-B342-4F9B-AC63-59C3BF6AA9F8Q43066084-DB68B216-2BB4-4742-9036-6091DAA3504BQ44294225-CDF53B80-AAB4-44C3-A91C-D9ADB1A0373AQ44562252-5A6CC8C5-B218-40E5-A5BD-DCB9C67BB1F1Q44771047-7AF10CA1-3F11-4E37-9494-848D6506D5DCQ44817934-555FAC3E-018B-4BC7-92D9-492F1FC1E62DQ45357136-3E3F9D2E-F289-4BA6-AE12-42C7B3F2EA82Q46259831-196918C2-1ADB-4ABE-AAC3-6379383C37CCQ46578520-354DBE1E-117C-49C3-894D-734AD0428EC7Q46894368-28D620DA-F1E9-4AAF-A967-C7FE05DC5471Q47609334-9419172F-14BD-436F-AD5A-910D367763F2Q48722523-D235BC0D-CE03-40AF-AB5D-12AE87EF1288Q50352022-A30B3B3F-B554-4828-B4D2-11BEAFFDBCAAQ50352491-ABEA5D8D-14D0-4E21-95D6-6C9990A1CECFQ50422766-A332D692-2453-4C6C-9109-04BADE945FFFQ50434329-08A4ADC3-9A6B-4306-93B7-30361296E9D4Q50441623-C6CC8B58-0B34-4B9E-AA4F-A5F4A7625BAEQ50448446-892C3EB8-D4D4-4116-92CE-32C0F37F963CQ50453777-722E1351-D7DD-4ABF-88B9-55D48000C5E5Q50458094-46D47737-5EFD-4A54-AA7B-9636798FDCDAQ50463796-B21CE211-B1D8-49F1-8CF3-EF0044F422F0Q50463813-63762C53-5F0B-4AC1-A120-972E1AF07FD0Q50466477-B7D29B72-72E9-40B1-97FA-EEDA53C01EDFQ50470560-EF907CAA-8651-4658-8985-10C67FA74A3C
P50
description
researcher
@en
wetenschapper
@nl
name
García Berrocal JR
@nl
José Ramón García Berrocal
@en
type
label
García Berrocal JR
@nl
José Ramón García Berrocal
@en
altLabel
JOSÉ RAMÓN GARCÍA-BERROCAL
@en
prefLabel
García Berrocal JR
@nl
José Ramón García Berrocal
@en
P106
P31
P496
0000-0003-2747-2991